Join the Lumify group to help and get support from people like you.
Lumify News
Bausch + Lomb Receives FDA Approval of Lumify Preservative Free Redness Reliever Eye Drops
VAUGHAN, Ontario, April 26, 2024 – Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced t...
FDA Medwatch Alert: FDA Warns Consumers of Contaminated Copycat Eye Drops
January 31, 2024 – FDA is warning consumers not to purchase or use South Moon, Rebright or FivFivGo eye drops because of the potential risk of eye infection. These are copycat eye drop products that...
FDA Warns of Dangerous Counterfeit Eyedrops
THURSDAY, Feb. 1, 2024 – Certain copycat eyedrops may be contaminated and could give users an antibiotic-resistant eye infection, the U.S. Food and Drug Administration warned Wednesday. The...
Bausch + Lomb Receives FDA Approval of Lumify (brimonidine tartrate) Over-the-Counter Eye Drop for the Treatment of Eye Redness
LAVAL, Quebec, Dec. 22, 2017 /PRNewswire/ – Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX)...
Ask a question
To post your own question to this support group, sign in or create an account.